Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase - Concepedia

Concepedia

Publication | Closed Access

Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase

22

Citations

22

References

2017

Year

Jagroop Kaur, Baljit Kaur, Palwinder Singh

Bioorganic & Medicinal Chemistry Letters

Signal TransductionMedicineTyrosine KinaseReceptor Tyrosine KinaseCancer GrowthAnti-cancer AgentTumor SuppressorPharmacologyCell BiologyCell SignalingTumor BiologyRational ModificationTumor Growth Inhibitor

References

	Year	Citations

Page 1